# A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

> **NCT00402324** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 202 (actual)

## Conditions studied

- Bipolar I Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** placebo
- **DRUG:** divalproex

## Key facts

- **NCT ID:** NCT00402324
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2009-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402324, "A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00402324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*